Cooper, Maureen External Author

Publications

Sort by

Selected publications

  • A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemiaLeukemia Research. 2006 Information Resource GET IT
    Times cited: 24